secwatch.observer — SEC 8-K summary
======================================

Issuer:     GILEAD SCIENCES, INC. (GILD)
CIK:        0000882095
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0000882095-24-000016
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gilead stockholders approve officer exculpation amendment, elect directors, pass say-on-pay
--------------------------------------------------------------------------------

- Officer exculpation amendment approved with 905.5M for, 101.7M against (85.6% support).
- All nine director nominees elected; CEO Daniel O'Day received 939.1M for, 63.1M against.
- Advisory say-on-pay passed with 928.7M for, 78.6M against (91.7% of votes cast).
- Ernst & Young ratified as auditor with 1.04B for, 74.1M against.
- Three stockholder proposals (employee board seat, abortion risk report, equity retention) all defeated by wide margins.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882095/000088209524000016/0000882095-24-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882095/000088209524000016/gild-20240508.htm
  HTML page:      https://secwatch.observer/filing/0000882095-24-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer